Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M12,747Revenue $M730Net Margin (%)11.8Z-Score44.5
Enterprise Value $M11,890EPS $1.1Operating Margin %16.8F-Score5
P/E(ttm))201Cash Flow Per Share $0.2Pre-tax Margin (%)16.8Higher ROA y-yN
Price/Book19.810-y EBITDA Growth Rate %0Quick Ratio5.1Cash flow > EarningsY
Price/Sales23.15-y EBITDA Growth Rate %0Current Ratio5.2Lower Leverage y-yY
Price/Cash Flow306y-y EBITDA Growth Rate %31.1ROA % (ttm)9.9Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)12.3Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M75.5ROI % (ttm)2.8Gross Margin Increase y-yN

Gurus Latest Trades with PCYC

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PCYCJoel Greenblatt 2014-12-31 Buy $103.79 - $141.55
($128.16)
$ 215.9368%New holding, 2619 sh.2,619
PCYCKen Fisher 2014-09-30 Reduce$91.5 - $127.81
($114.49)
$ 215.9389%Reduce -36.57%3,244
PCYCJoel Greenblatt 2014-09-30 Sold Out -0.09%$91.5 - $127.81
($114.49)
$ 215.9389%Sold Out0
PCYCJoel Greenblatt 2014-06-30 Add0.08%$85.85 - $107.42
($93.89)
$ 215.93130%Add 724.62%79,089
PCYCKen Fisher 2014-06-30 Buy $85.85 - $107.42
($93.89)
$ 215.93130%New holding, 5114 sh.5,114
PCYCMariko Gordon 2014-06-30 Sold Out -0.04%$85.85 - $107.42
($93.89)
$ 215.93130%Sold Out0
PCYCMariko Gordon 2014-03-31 Add0.02%$100.49 - $151.61
($129.71)
$ 215.9366%Add 112.41%9,295
PCYCJoel Greenblatt 2014-03-31 Buy 0.01%$100.49 - $151.61
($129.71)
$ 215.9366%New holding, 9591 sh.9,591
PCYCMariko Gordon 2013-12-31 Add0.01%$99.28 - $139.59
($121.32)
$ 215.9378%Add 130.07%4,376
PCYCMariko Gordon 2013-09-30 Buy 0.01%$84.5 - $132.49
($110.93)
$ 215.9395%New holding, 1902 sh.1,902
PCYCJoel Greenblatt 2013-03-31 Sold Out -0.14%$57.78 - $94.2
($77.47)
$ 215.93179%Sold Out0
PCYCJoel Greenblatt 2012-12-31 Buy 0.14%$47.87 - $69.78
($58.72)
$ 215.93268%New holding, 41832 sh.41,832
PCYCGeorge Soros 2012-06-30 Sold Out -0.04%$25.72 - $53.44
($32.62)
$ 215.93562%Sold Out0
PCYCGeorge Soros 2012-03-31 Buy 0.04%$14.99 - $28.68
($20.91)
$ 215.93933%New holding, 100000 sh.100,000
PCYCPRIMECAP Management 2011-06-30 Add0.01%$5.66 - $10.63
($7.17)
$ 215.932912%Add 21.34%4,011,958
PCYCPRIMECAP Management 2010-06-30 Add0.01%$5.53 - $8.18
($6.98)
$ 215.932994%Add 43.36%3,306,481
PCYCPRIMECAP Management 2009-09-30 Add$1.2299 - $2.32
($1.49)
$ 215.9314392%Add 51.48%2,300,678
PCYCPRIMECAP Management 2009-06-30 Reduce$1.02 - $1.39
($1.24)
$ 215.9317314%Reduce -27.71%1,518,800
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PCYC is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
PCYC Joel Greenblatt 2014-12-312,61900New Buy
PCYC Ken Fisher 2014-12-313,26400+0.62%
PCYC PRIMECAP Management 2014-12-312,310,5393.040.29-0.02%
Premium Most recent portfolio changes are included for Premium Members only!


PCYC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Fardis MariaChief of Oncology Ops & Allian 2014-11-13Sell3,000$141.352.82view
Soni Manmeet SinghCFO 2014-11-13Sell1,000$141.4452.67view
Zanganeh MakyCOO 2014-11-12Sell30,482$134.6960.32view
Love Richard BGeneral Counsel 2014-11-10Sell1,500$133.8761.3view
Fardis MariaChief of Oncology Ops & Allian 2014-11-07Sell5,000$134.560.54view
Zanganeh MakyCOO 2014-09-04Sell12,000$121.7577.36view
Love Richard BGeneral Counsel 2014-08-27Sell1,500$12474.14view
Fardis MariaChief of Oncology Ops & Allian 2014-08-13Sell4,000$121.0178.44view
Tan HeowChief Quality&Tech Operations 2014-08-13Sell10,000$123.5874.73view
McGreivy JesseChief Medical Officer 2014-08-07Sell34,062$120.9278.57view

Press Releases about PCYC :

    Quarterly/Annual Reports about PCYC:

    News about PCYC:

    Articles On GuruFocus.com
    Weekly 52-Week Highs Highlight: DG, AGN, ADSK, AVGO, PCYC Feb 22 2015 
    Weekly Insider Sells Highlight: BX, PCYC, MAS, ITMN Mar 03 2014 
    comment on PCYC Mar 06 2013 
    Weekly CEO Buys Highlight: PCYC, HLX, FSC, CREG, BTX Jun 25 2011 
    Pharmacyclics Inc. Reports Operating Results (10-Q) Feb 08 2011 
    Pharmacyclics Inc. Reports Operating Results (10-Q) Nov 09 2010 
    Weekly CEO Buys Highlight: Pharmacyclics Inc, Saul Centers Inc, Charming Shoppes Inc, ProLogis, Exce Jun 27 2010 
    Pharmacyclics Inc. Reports Operating Results (10-Q) May 07 2010 
    cooldecency99 note on PCYC May 01 2010 
    cooldecency99 note on PCYC May 01 2010 


    More From Other Websites
    Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases Feb 27 2015
    2:34 pm Pharmacyclics announces that pre-clinical studies indicate Ibrutinib enhances anti-tumor... Feb 27 2015
    In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1... Feb 27 2015
    Cramer: Pharmacyclics-Johnson & Johnson Deal Unlikely at This Price Feb 27 2015
    Cramer's Stop Trading: PCYC Feb 27 2015
    The Zacks Analyst Blog Highlights: Pharmacyclics, Celgene, Amgen and Regeneron - Press Releases Feb 27 2015
    Biotech Making A Comeback - Here Is One Stock to Watch Feb 26 2015
    6 reasons biotech stocks may soon tank Feb 26 2015
    Biotech Stock Roundup: Pharmacyclics Up on Buyout Rumors, Celgene Drug Label Expanded - Analyst Blog Feb 26 2015
    Credit Suisse Downgrades Pharmacyclics Amid Takeover Rumors Feb 26 2015
    Familiar ETF Friend Will Enjoy a Pharmacyclics Sale Feb 26 2015
    Pharmacyclics (PCYC) Jumps 16.9% on Takeover Rumors - Analyst Blog Feb 26 2015
    Pharmacyclics downgraded by WallachBeth Feb 26 2015
    Cancer Drug Once Bought for $7 Million May Now Fetch $18 Billion Feb 25 2015
    Pharmacyclics said to weigh sale of U.S. cancer drugmaker Feb 25 2015
    Pharmacyclics considers $19bn sale Feb 25 2015
    Pharmacyclics Weighs Sale of $15 Billion U.S. Drugmaker Feb 25 2015
    Pharmacyclics mulls sale; J&J, Novartis interested - Bloomberg Feb 25 2015
    Biotech Pharmacyclics Spikes On Buyout Rumors Feb 25 2015
    Pharmacyclics Said to Weigh Sale of $15 Billion U.S. Drugmaker Feb 25 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK